Addresses the significant threat of antimicrobial resistance.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

If you buy something, we may earn an affiliate commission. The best jewelry brands do more than accessorize—they elevate, transform, and complete any outfit. As a jewelry designer, I know ...

At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal ...

Says therapeutic portfolio ‘demonstrating very strong momentum’ into 2025. Says making “significant progress” in R&D efforts. Published first on TheFly – the ultimate source for real ...

Trust is a cornerstone of meaningful relationships. When dealing with businesses and brands, it's often the deciding factor that separates companies we rely on from the ones we don't. It's about ...

The aim of the data-powered offering is to identify consumers who are predicted to be in the market for a brand’s product or service within the next three months. Marketers can use Brand+ to ...

Larsen & Toubro Group (L&T) also made a debut in the sector, with brand value at $7.4 billion while Bajaj Group's brand value was up 23% to $6 billion. Mahindra Group has increased its brand value by ...

In an earlier article, I shared personal experiences about launching a parent brand after a merger. To recap, the initial work begins with a strategic review of your brand portfolio and brand ...

SINGAPORE - China’s BYD was the best-selling car brand in Singapore in 2024, with 6,191 units registered, beating out Japan’s Toyota and Germany’s BMW. This is the first time a Chinese ...

(RTTNews) - AbbVie, Inc. (ABBV) and Neomorph, Inc. announced Thursday a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology ...